Trial Profile
Double-blind, prospective, randomized study of Trimetazidine in patients with non-ischemic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2015
Price :
$35
*
At a glance
- Drugs Trimetazidine (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 31 Oct 2015 New trial record